{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:13651"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:13651","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Interrogating a role for tumour necrosis factor alpha in CD4\\(^+\\) T cell metabolism in health and inflammatory disease","abstract":"Upon activation, CD4\\(^+\\) T cells undergo substantial metabolic reprogramming to support clonal expansion and effector function, largely promoted by T cell receptor (TCR) and CD28 signalling. Whether T cell-derived inflammatory cytokines, such as tumour necrosis factor alpha (TNF-α), amplify this process is not well understood but could be pertinent in chronic inflammatory diseases, such as rheumatoid arthritis (RA), where abundant TNF-α expression and dysregulated CD4\\(^+\\) T cell metabolic phenotypes are present. TNF-α has been previously identified to act as a co-stimulatory signal upon T cell activation, increasing proliferation and cytokine production. Yet, whether TNF-α controls CD4\\(^+\\) T cell metabolism has not been interrogated. Here, it was shown that blocking T cell-derived TNF-α supressed the activation of naïve CD4\\(^+\\) T cells and impaired their upregulation of glycolysis, amino acid uptake, and mitochondrial oxidation of glutamine. Conversely, addition of TNF-α was able to increase glycolysis in these cells. Interrogation of downstream signalling pathways identified that TNF-α drives these changes not through NFκB, which is most commonly reported to be downstream of TNF-α, but through the PI3K/Akt/mTOR pathway. T cell-derived TNF-α signalling was also shown to be involved in driving inflammatory T helper (Th)1 and Th17 cell differentiation in a partially Akt-dependent manner, whilst little effect on regulatory T cell (Treg) differentiation was observed. Finally, to interrogate a role for this TNF-α/PI3K/Akt metabolic axis in chronic inflammatory disease, peripheral blood CD4\\(^+\\) T cells from RA patients and healthy controls were analysed by flow cytometry. RA CD4\\(^+\\) T cells exhibited higher levels of membrane-bound TNF-α, mitochondrial mass, and Akt phosphorylation. These data implicate TNF-α signalling via PI3K/Akt in the dysregulated metabolic phenotype of RA CD4\\(^+\\) T cells.","abstract_html":"Upon activation, CD4<span class=\"etd-inline-math\"><sup>+</sup></span> T cells undergo substantial metabolic reprogramming to support clonal expansion and effector function, largely promoted by T cell receptor (TCR) and CD28 signalling. Whether T cell-derived inflammatory cytokines, such as tumour necrosis factor alpha (TNF-α), amplify this process is not well understood but could be pertinent in chronic inflammatory diseases, such as rheumatoid arthritis (RA), where abundant TNF-α expression and dysregulated CD4<span class=\"etd-inline-math\"><sup>+</sup></span> T cell metabolic phenotypes are present. TNF-α has been previously identified to act as a co-stimulatory signal upon T cell activation, increasing proliferation and cytokine production. Yet, whether TNF-α controls CD4<span class=\"etd-inline-math\"><sup>+</sup></span> T cell metabolism has not been interrogated. Here, it was shown that blocking T cell-derived TNF-α supressed the activation of naïve CD4<span class=\"etd-inline-math\"><sup>+</sup></span> T cells and impaired their upregulation of glycolysis, amino acid uptake, and mitochondrial oxidation of glutamine. Conversely, addition of TNF-α was able to increase glycolysis in these cells. Interrogation of downstream signalling pathways identified that TNF-α drives these changes not through NFκB, which is most commonly reported to be downstream of TNF-α, but through the PI3K/Akt/mTOR pathway. T cell-derived TNF-α signalling was also shown to be involved in driving inflammatory T helper (Th)1 and Th17 cell differentiation in a partially Akt-dependent manner, whilst little effect on regulatory T cell (Treg) differentiation was observed. Finally, to interrogate a role for this TNF-α/PI3K/Akt metabolic axis in chronic inflammatory disease, peripheral blood CD4<span class=\"etd-inline-math\"><sup>+</sup></span> T cells from RA patients and healthy controls were analysed by flow cytometry. RA CD4<span class=\"etd-inline-math\"><sup>+</sup></span> T cells exhibited higher levels of membrane-bound TNF-α, mitochondrial mass, and Akt phosphorylation. These data implicate TNF-α signalling via PI3K/Akt in the dysregulated metabolic phenotype of RA CD4<span class=\"etd-inline-math\"><sup>+</sup></span> T cells.","abstract_has_math":true,"creators":["Bishop, Emma Louise"],"institution":"University of Birmingham","degree_name":"d_ph","degree_level":"d_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2023,"date_issued":"2023-07","date_published":"2023-07","updated_at":"2026-11-19T09:32:19Z","subjects":["QH301 Biology","QR180 Immunology"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[{"key":"person:identifier.orcid","label":"ORCID","values":["0000000234807764"],"render_values":[{"text":"0000-0002-3480-7764","href":"https://orcid.org/0000-0002-3480-7764","code":true}]}]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/13651/1/Bishop2023PhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A13651","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["wellcome_trust"]},{"key":"dc:creator","label":"Author","values":["Bishop, Emma Louise"]},{"key":"person:identifier.orcid","label":"ORCID","values":["0000000234807764"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2023-07-14"]},{"key":"dc:date.issued","label":"Date","values":["2023-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","Institute of Immunology and Immunotherapy"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/13651/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_ph"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["QH301 Biology","QR180 Immunology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/13651/1/Bishop2023PhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Upon activation, CD4\\(^+\\) T cells undergo substantial metabolic reprogramming to support clonal expansion and effector function, largely promoted by T cell receptor (TCR) and CD28 signalling. Whether T cell-derived inflammatory cytokines, such as tumour necrosis factor alpha (TNF-α), amplify this process is not well understood but could be pertinent in chronic inflammatory diseases, such as rheumatoid arthritis (RA), where abundant TNF-α expression and dysregulated CD4\\(^+\\) T cell metabolic phenotypes are present. TNF-α has been previously identified to act as a co-stimulatory signal upon T cell activation, increasing proliferation and cytokine production. Yet, whether TNF-α controls CD4\\(^+\\) T cell metabolism has not been interrogated. Here, it was shown that blocking T cell-derived TNF-α supressed the activation of naïve CD4\\(^+\\) T cells and impaired their upregulation of glycolysis, amino acid uptake, and mitochondrial oxidation of glutamine. Conversely, addition of TNF-α was able to increase glycolysis in these cells. Interrogation of downstream signalling pathways identified that TNF-α drives these changes not through NFκB, which is most commonly reported to be downstream of TNF-α, but through the PI3K/Akt/mTOR pathway. T cell-derived TNF-α signalling was also shown to be involved in driving inflammatory T helper (Th)1 and Th17 cell differentiation in a partially Akt-dependent manner, whilst little effect on regulatory T cell (Treg) differentiation was observed. Finally, to interrogate a role for this TNF-α/PI3K/Akt metabolic axis in chronic inflammatory disease, peripheral blood CD4\\(^+\\) T cells from RA patients and healthy controls were analysed by flow cytometry. RA CD4\\(^+\\) T cells exhibited higher levels of membrane-bound TNF-α, mitochondrial mass, and Akt phosphorylation. These data implicate TNF-α signalling via PI3K/Akt in the dysregulated metabolic phenotype of RA CD4\\(^+\\) T cells."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Interrogating a role for tumour necrosis factor alpha in CD4\\(^+\\) T cell metabolism in health and inflammatory disease"]}]}],"canonical_facts":{"dc:contributor.sponsor":["wellcome_trust"],"dc:creator":["Bishop, Emma Louise"],"dc:date":["2023-07-14"],"dc:date.issued":["2023-07"],"dc:description.abstract":["Upon activation, CD4\\(^+\\) T cells undergo substantial metabolic reprogramming to support clonal expansion and effector function, largely promoted by T cell receptor (TCR) and CD28 signalling. Whether T cell-derived inflammatory cytokines, such as tumour necrosis factor alpha (TNF-α), amplify this process is not well understood but could be pertinent in chronic inflammatory diseases, such as rheumatoid arthritis (RA), where abundant TNF-α expression and dysregulated CD4\\(^+\\) T cell metabolic phenotypes are present. TNF-α has been previously identified to act as a co-stimulatory signal upon T cell activation, increasing proliferation and cytokine production. Yet, whether TNF-α controls CD4\\(^+\\) T cell metabolism has not been interrogated. Here, it was shown that blocking T cell-derived TNF-α supressed the activation of naïve CD4\\(^+\\) T cells and impaired their upregulation of glycolysis, amino acid uptake, and mitochondrial oxidation of glutamine. Conversely, addition of TNF-α was able to increase glycolysis in these cells. Interrogation of downstream signalling pathways identified that TNF-α drives these changes not through NFκB, which is most commonly reported to be downstream of TNF-α, but through the PI3K/Akt/mTOR pathway. T cell-derived TNF-α signalling was also shown to be involved in driving inflammatory T helper (Th)1 and Th17 cell differentiation in a partially Akt-dependent manner, whilst little effect on regulatory T cell (Treg) differentiation was observed. Finally, to interrogate a role for this TNF-α/PI3K/Akt metabolic axis in chronic inflammatory disease, peripheral blood CD4\\(^+\\) T cells from RA patients and healthy controls were analysed by flow cytometry. RA CD4\\(^+\\) T cells exhibited higher levels of membrane-bound TNF-α, mitochondrial mass, and Akt phosphorylation. These data implicate TNF-α signalling via PI3K/Akt in the dysregulated metabolic phenotype of RA CD4\\(^+\\) T cells."],"dc:format":["text"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/13651/1/Bishop2023PhD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","Institute of Immunology and Immunotherapy"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/13651/"],"dc:subject":["QH301 Biology","QR180 Immunology"],"dcterms:accessrights":["public"],"dc:title":["Interrogating a role for tumour necrosis factor alpha in CD4\\(^+\\) T cell metabolism in health and inflammatory disease"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_ph"],"dc:type.qualificationname":["d_ph"],"person:identifier.orcid":["0000000234807764"]},"updated_at":"2026-11-19T09:32:19Z"}